DR. KISHOR BHATIA TO HEAD NATIONAL CANCER INSTITUTE AIDS MALIGNANCY PROGRAM

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



U.S. Department of Health and Human Services 
NATIONAL INSTITUTES OF HEALTH 
NIH News 
National Cancer Institute (NCI) 
http://www.cancer.gov/

FOR IMMEDIATE RELEASE: Tuesday, November 1, 2005  

CONTACT: NCI Media Relations Branch, 301-496-6641,
ncipressofficers@xxxxxxxxxxxx 
 
DR. KISHOR BHATIA TO HEAD NATIONAL CANCER INSTITUTE AIDS MALIGNANCY
PROGRAM 

The National Cancer Institute (NCI), part of the National Institutes of
Health (NIH), has announced the appointment of Kishor Bhatia, Ph.D., as
director of the new AIDS Malignancy Program (AMP). Bhatia has served as
the program director for the Cancer Diagnosis Program, Division of
Cancer Treatment and Diagnosis, since 2004 and his appointment to AMP
was effective Oct. 2, 2005. 

The AMP is designed to support extramural (research funded by, but not
conducted at, the NCI) HIV and AIDS malignancy research. The AMP will
coordinate all AIDS and AIDS oncology efforts across NCI, including the
development of extramural initiatives and AIDS co-funding agreements.
Existing projects that will be managed by the AMP include the AIDS and
Cancer Specimen Resource, the Women's Interagency HIV Study, the
Multicenter AIDS cohort study, and the AIDS International Training and
research Program. The AMP also will work closely with the Centers for
AIDS Research (CFAR) at the NIH, providing administrative and research
support for AIDS research projects. 

Working together, these two programs will emphasize the importance of
collaboration between disciplines and between basic and clinical
investigators, research in which laboratory discoveries are translated
into clinical practice, and the importance of research on prevention and
behavioral change. As part of the Cancer Therapy Evaluation Program
within the Division of Cancer Treatment and Diagnosis, Bhatia will
report directly to Mark Clanton, M.D., deputy director for Cancer
Delivery Systems. 

Bhatia worked at the NCI Pediatric Branch from 1989 through 1997 as a
senior staff fellow, and as a senior staff scientist from 1997 through
2000. During that time he was also an assistant professor at the
Uniformed Services University of Health Sciences in Bethesda, Md. From
1999 through 2004, he served as the director of the Translational
Program in the International Network for Cancer Treatment and Research
at the Institute Louis Pasteur in Brussels, Belgium. He went on to serve
as director of the research center at the Children's Cancer Center at
King Faisal Hospital in Riyadh, Saudi Arabia, from 2000 to 2004, while
also teaching as an adjunct professor in the Department of Pathology at
the University of Nebraska in Omaha. 

Bhatia received a B.S. in microbiology from Pune University in Pune,
India. He later received a Ph.D. in biochemistry from the University of
Bombay in Mumbai, India; he achieved membership in the British Royal
College of Pathology in 2003. 

In addition to the cellular and molecular biology of cancers related to
infectious disease, Bhatia also is interested in strengthening research
networks in developing countries. He participated in the development of
the Middle Eastern Cancer Society in 1994, and serves as a member of the
NIH Working Group on Capacity Building for International Research. 

"We're very pleased to have Dr. Bhatia at the helm of this new office,"
said NCI Director Andrew C. von Eschenbach, M.D. "His work with
hematologic cancers and with research organizations around the globe
will be invaluable to the AIDS Malignancy Program." 

For more information about cancer, visit the NCI Web site at
http://www.cancer.gov or call NCI's Cancer Information Service at
1-800-4 CANCER (1-800-422-6237). 

The National Institutes of Health (NIH) -- "The Nation's Medical
Research Agency" -- includes 27 Institutes and Centers and is a
component of the U. S. Department of Health and Human Services. It is
the primary Federal agency for conducting and supporting basic,
clinical, and translational medical research, and it investigates the
causes, treatments, and cures for both common and rare diseases. For
more information about NIH and its programs, visit http://www.nih.gov.
  
##
 
This NIH News Release is available online at:
http://www.nih.gov/news/pr/nov2005/nci-01.htm.

To subscribe (or unsubscribe) from this list, go to
http://list.nih.gov/cgi-bin/wa?SUBED1=nihpress&A=1.

[Index of Archives]     [CDC News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux